Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study

Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study

Hiroo Imai, Ken Saijo, Keigo Komine, Reio Ueta, Ryunosuke Numakura, Shonosuke Wakayama, Sho Umegaki, Sakura Hiraide, Yoshufumi Kawamura, Yuki Kasahara, Kota Ohuchi, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka Department of Medical Oncology, Tohoku Unive...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Imai H, Saijo K, Komine K, Ueta R, Numakura R, Wakayama S, Umegaki S, Hiraide S, Kawamura Y, Kasahara Y, Ohuchi K, Takahashi M, Takahashi S, Shirota H, Ishioka C
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Dove Medical Press 2022-03-01
Reeks:	Cancer Management and Research
Onderwerpen:	gastric cancer chemotherapy oxaliplatin antibiotics
Online toegang:	https://www.dovepress.com/antibiotic-treatment-improves-the-efficacy-of-oxaliplatin-based-therap-peer-reviewed-fulltext-article-CMAR

Gelijkaardige items

Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
door: Mohammad Ali Mashhadi, et al.
Gepubliceerd in: (2016-10-01)

Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
door: Guoxiu Wang, et al.
Gepubliceerd in: (2018-05-01)

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
door: Yuanyuan Yu, et al.
Gepubliceerd in: (2021-05-01)

Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
door: Fei-Yu Wang, et al.
Gepubliceerd in: (2025-03-01)

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy
door: Qian J, et al.
Gepubliceerd in: (2016-02-01)

Modified biweekly oxaliplatin and capecitabine for advanced gastric cancer: A retrospective analysis from a medical center
door: Yung-Chia Kuo, et al.
Gepubliceerd in: (2014-06-01)

S-1 and oxaliplatin regimen neoadjuvant chemotherapy followed by surgery for resectable advanced gastric cancer with multiple lymph-node metastasis
door: T. Udaka, et al.
Gepubliceerd in: (2022-05-01)

Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer
door: Imai H, et al.
Gepubliceerd in: (2018-09-01)

Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
door: Masato Kondo, et al.
Gepubliceerd in: (2020-06-01)

Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
door: Xinxin Wang, et al.
Gepubliceerd in: (2024-04-01)

Polyene phosphatidylcholine enhances the therapeutic response of oxaliplatin in gastric cancer through Nrf2/HMOX1 mediated ferroptosis
door: Peijie Lei, et al.
Gepubliceerd in: (2024-05-01)

Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer
door: Yasuyuki Kawamoto, et al.
Gepubliceerd in: (2017-12-01)

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol
door: Tsutomu Namikawa, et al.
Gepubliceerd in: (2018-02-01)

Oxaliplatin-Associated Amaurosis Fugax
door: Kimitoshi Kubo, et al.
Gepubliceerd in: (2021-06-01)

A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)
door: Hirokazu Shoji, et al.
Gepubliceerd in: (2021-08-01)

A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)
door: Ezanno Anne-Cecile, et al.
Gepubliceerd in: (2022-01-01)

Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats
door: Nobuaki Egashira, et al.
Gepubliceerd in: (2021-09-01)

Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis
door: Qixuan Xu, et al.
Gepubliceerd in: (2024-08-01)

Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
door: Kabsoo Shin, et al.
Gepubliceerd in: (2019-12-01)

Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients’ FOXP1 and GGT levels
door: Xinyu Guo, et al.
Gepubliceerd in: (2025-01-01)

Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients' FOXP1 and GGT levels
door: Xinyu Guo, et al.
Gepubliceerd in: (2024-11-01)

The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial
door: Xinxin Wang, et al.
Gepubliceerd in: (2021-01-01)

Polymorphisms of ERCC1, XPD, XRCC1 and XPG Predict Clinical Outcome in Advanced Gastric Cancer Patients Receiving Oxaliplatin-Based Chemotherapy in Chinese Population
door: Jian JIANG, et al.
Gepubliceerd in: (2009-10-01)

PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: A network meta-analysis
door: Xiaoyu Guo, et al.
Gepubliceerd in: (2022-08-01)

Antibiotic therapy augments the efficacy of gemcitabine-containing regimens for advanced cancer: a retrospective study
door: Imai H, et al.
Gepubliceerd in: (2019-08-01)

Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy
door: Hiroshi Saeki, et al.
Gepubliceerd in: (2018-01-01)

Establishment of the menthol test as a clinical evaluation method for oxaliplatin-induced neuropathy
door: Yeongcheol Cheong, et al.
Gepubliceerd in: (2022-08-01)

Oxaliplatin Promotes Apoptosis of Gastric Cancer Cell Line SGC-7901 by Regulating miRNA-7-5p/RAF-1
door: GU Zehui, et al.
Gepubliceerd in: (2020-03-01)

Ferroptosis-related oxaliplatin resistance in multiple cancers: Potential roles and therapeutic Implications
door: Sijia Zhong, et al.
Gepubliceerd in: (2024-09-01)

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
door: Qing-nan Zhou, et al.
Gepubliceerd in: (2023-05-01)

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)
door: Hiroaki Tanioka, et al.
Gepubliceerd in: (2019-10-01)

Chinese herbal medicine combined with oxaliplatin-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis of contributions of specific medicinal materials to tumor response
door: Ying Tan, et al.
Gepubliceerd in: (2022-08-01)

Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trial
door: Jianming Xu, et al.
Gepubliceerd in: (2021-01-01)

Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
door: Elizabeth Pan, et al.
Gepubliceerd in: (2018-12-01)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
door: Yu S, et al.
Gepubliceerd in: (2020-10-01)

A case of tongue swelling after S-1, oxaliplatin, and trastuzumab for HER2-positive gastric cancer
door: Taichi Abe, et al.
Gepubliceerd in: (2023-11-01)

Relapsed urachal carcinoma responding to first‐line chemotherapy with capecitabine‐oxaliplatin plus bevacizumab
door: Akihiko Hatano, et al.
Gepubliceerd in: (2023-11-01)

Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis
door: Diana Groza, et al.
Gepubliceerd in: (2018-05-01)

Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent Chemotherapy
door: Yixin Yin, et al.
Gepubliceerd in: (2022-09-01)

Long-term survival in metastatic gastric cancer patient with Apatinib plus S-1 maintenance treatment following first-line chemotherapy—case report
door: Zhen Wang, et al.
Gepubliceerd in: (2024-11-01)